300149 睿智醫藥
按盤價 
9.380 -0.020 (-0.213%)
9.380 -0.020 (-0.213%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.419 | 1.077 | -17.089 | -48.477 | 16.827 |
| 總資產報酬率 ROA (%) | -0.892 | 0.666 | -10.224 | -29.372 | 9.037 |
| 投入資產回報率 ROIC (%) | -1.007 | 0.748 | -11.502 | -32.939 | 10.070 | 邊際利潤分析 |
| 銷售毛利率 (%) | 22.146 | 28.615 | 21.800 | 25.935 | 25.423 |
| 營業利潤率 (%) | -8.743 | 2.035 | -22.350 | -82.255 | 56.350 |
| 息稅前利潤/營業總收入 (%) | -5.824 | 2.248 | -23.476 | -81.322 | 55.826 |
| 淨利潤/營業總收入 (%) | -6.760 | 1.194 | -23.347 | -80.549 | 27.320 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.229 | 113.542 | 26.521 | 6.392 | -11.315 |
| 價值變動淨收益/利潤總額(%) | 0.495 | 75.911 | -3.365 | 0.098 | 190.871 |
| 營業外收支淨額/利潤總額(%) | 0.522 | -44.186 | 6.392 | 0.362 | -2.575 | 償債能力分析 |
| 流動比率 (X) | 2.134 | 2.152 | 1.858 | 1.704 | 1.749 |
| 速動比率 (X) | 2.089 | 2.126 | 1.825 | 1.639 | 1.691 |
| 資產負債率 (%) | 35.715 | 36.036 | 37.967 | 39.988 | 37.762 |
| 帶息債務/全部投入資本 (%) | 10.135 | 10.273 | 10.546 | 10.329 | 15.544 |
| 股東權益/帶息債務 (%) | 705.134 | 686.166 | 648.516 | 643.036 | 443.387 |
| 股東權益/負債合計 (%) | 175.976 | 174.180 | 160.194 | 147.585 | 163.121 |
| 利息保障倍數 (X) | -1.964 | 2.687 | -58.773 | -66.008 | 62.684 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 79.098 | 64.400 | 81.738 | 95.718 | 91.814 |
| 存貨周轉天數 (天) | 5.645 | 4.647 | 9.329 | 15.094 | 20.310 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 19/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
